Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Biomarkers of Adverse Neurologic Outcome in Newborns at Risk for Perinatal Brain Injury - Study on Neuro-developmental Follow-up at 2 Years A Prospective Multicenter Observational Study for Development of a Diagnostic Test

NCT04714775 is registered in ClinicalTrials.gov with InfanDx AG as lead sponsor.

NCT NCT04714775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04714775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Biomarkers of Adverse Neurologic Outcome in Newborns at Risk for Perinatal Brain Injury - Study on Neuro-developmental Follow-up at 2 Years A Prospective Multicenter Observational Study for Development of a Diagnostic Test
Lead sponsor
InfanDx AG
Phase
Observational
Overall status
Unknown status
Start date
February 5, 2019
Completion date
December 31, 2021
Enrollment
500 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

asphyxia neonatorum